Weihai Dongxun Biotechnology Co., Ltd announced that it has signed a capital increase agreement for gross proceeds of CNY 40 million on March 4, 2022. The transaction will include participation from new investor Vanfund Urban Investment and Development Co., Ltd. and will hold 24% stake and from returning investor Runtian Light Beijing Agricultural Technology Co., Ltd and will hold 76% pursuant to the transaction. The registered capital will increase from CNY 10 million to CNY 50 million.

The transaction does not need general meeting of shareholders.